Publications by authors named "Bleranda Zeka"

Claim this Profile
L
Local Tumour Control Following Microwave Ablation: Protocol for the Prospective Observational CIEMAR Study.
Philippe L Pereira, Reto Bale, Åsmund Avdem Fretland, S Nahum Goldberg, Thomas Helmberger, Bleranda Zeka

Cardiovasc Intervent Radiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Local Tumour Control Following Microwave Ablation: Protocol for the Prospective Observational CIEMAR Study.
Philippe L Pereira, Reto Bale, Åsmund Avdem Fretland, S Nahum Goldberg, Thomas Helmberger, Bleranda Zeka

Cardiovasc Intervent Radiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research in interventional oncology: How sound is the evidence base?
Nathalie C Kaufmann, Bleranda Zeka, Philippe L Pereira

J Med Imaging Radiat Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
Geert Maleux, Thomas Albrecht, Dirk Arnold, Irene Bargellini, Roberto Cianni, Bleranda Zeka

Cardiovasc Intervent Radiol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
Frank Kolligs, Dirk Arnold, Rita Golfieri, Maciej Pech, Bora Peynircioglu, Bleranda Zeka

JHEP Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT.
Niklaus Schaefer, Gerd Grözinger, Maciej Pech, Thomas Pfammatter, Cigdem Soydal, Bleranda Zeka

Clin Colorectal Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Feasibility and Technical Considerations from a Prospective, Observational Study-CIREL: Irinotecan-TACE for CRLM in 152 Patients.
Thomas Helmberger, Pierleone Lucatelli, Philippe L Pereira, Aleksandar Gjoreski, Ivona Jovanoska, Bleranda Zeka

J Clin Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis.
Philippe L Pereira, Roberto Iezzi, Riccardo Manfredi, Francesca Carchesio, Zoltan Bánsághi, Bleranda Zeka

Cardiovasc Intervent Radiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.
Philippe L Pereira, Dirk Arnold, Thierry de Baère, Fernando Gomez, Thomas Helmberger, Bleranda Zeka

Dig Liver Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.
Irina Tsymala, Magdalini Nigritinou, Bleranda Zeka, Rouven Schulz, Felix Niederschick

Acta Neuropathol Commun· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
Patrick Peschl, Kathrin Schanda, Bleranda Zeka, Katherine Given, Denise Böhm

J Neuroinflammation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder.
Bleranda Zeka, Hans Lassmann, Monika Bradl

Clin Exp Neuroimmunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
Satoru Oji, Eva-Maria Nicolussi, Nathalie Kaufmann, Bleranda Zeka, Kathrin Schanda

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.
Bleranda Zeka, Maria Hastermann, Nathalie Kaufmann, Kathrin Schanda, Marko Pende

Acta Neuropathol Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.
Bleranda Zeka, Maria Hastermann, Sonja Hochmeister, Nikolaus Kögl, Nathalie Kaufmann

Acta Neuropathol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis